五、問答題：閱讀以下治療指引並回答問题：(共15分)

(3) List one SGLT2 inhibitor and one GLP-1 RA with demonstrated cardiovascular benefit recommended for T2DM patients who have established ASCVD or indicators of high risk, established kidney disease or heart failure. (4 points)